Use of electronic medical records and biomarkers to manage risk and resource efficiencies

Dermot Ryan (Corresponding Author), John Blakey, Alison Chisholm, David Price, Mike Thomas, Björn Ställberg, Karin Lisspers, Janwillem W H Kocks, The Respiratory Effectiveness Group

Research output: Contribution to journalArticle

3 Downloads (Pure)

Abstract

The migration from paper to electronic medical records (EMRs) was motivated by the administrative need to record, retrieve and process increasing amounts of clinical data in the 1980s. In the intervening period, there has been growing recognition of the potential of such records for achieving care efficiencies, informing clinical decision making and real-life research. EMRs can be used to characterise patient groups, management approaches and differential outcomes. Characterisation can also help with identification of potential biomarkers for future risk determination and likely treatment response. The future heralds even greater opportunities through integration of clinical records and a range of technology-based solutions within a more complete electronic health record (EHR). Through application of algorithms based on identified risk predictors and disease determinants, clinical records could also be used to enable risk stratification of patients to optimise targeted interventions, conserving resources to achieve individual patient and system-wide benefit. In this review, we reflect on the evolution of the EMR and EHR and discuss current and emerging opportunities, particularly with respect to biomarkers and targeting of innovative biologic interventions. We also consider some of the critical issues associated with realising the potential of the EHR as a clinical aid and research tool in an age of emerging technologies.​​​​
Original languageEnglish
Article number1293386
JournalEuropean Clinical Respiratory Journal
Volume4
Issue number1
Early online date14 Mar 2017
DOIs
Publication statusPublished - 2017

Fingerprint

Electronic Health Records
Biomarkers
Medical Electronics
Technology
Research

Keywords

  • electronic medical record (EMR)
  • electronic health record (EHR)
  • database
  • asthma
  • biomarker
  • primary care
  • CDSS
  • big data

Cite this

Ryan, D., Blakey, J., Chisholm, A., Price, D., Thomas, M., Ställberg, B., ... The Respiratory Effectiveness Group (2017). Use of electronic medical records and biomarkers to manage risk and resource efficiencies. European Clinical Respiratory Journal , 4(1), [1293386 ]. https://doi.org/10.1080/20018525.2017.1293386

Use of electronic medical records and biomarkers to manage risk and resource efficiencies. / Ryan, Dermot (Corresponding Author); Blakey, John; Chisholm, Alison; Price, David; Thomas, Mike; Ställberg, Björn; Lisspers, Karin; Kocks, Janwillem W H; The Respiratory Effectiveness Group.

In: European Clinical Respiratory Journal , Vol. 4, No. 1, 1293386 , 2017.

Research output: Contribution to journalArticle

Ryan, D, Blakey, J, Chisholm, A, Price, D, Thomas, M, Ställberg, B, Lisspers, K, Kocks, JWH & The Respiratory Effectiveness Group 2017, 'Use of electronic medical records and biomarkers to manage risk and resource efficiencies' European Clinical Respiratory Journal , vol. 4, no. 1, 1293386 . https://doi.org/10.1080/20018525.2017.1293386
Ryan, Dermot ; Blakey, John ; Chisholm, Alison ; Price, David ; Thomas, Mike ; Ställberg, Björn ; Lisspers, Karin ; Kocks, Janwillem W H ; The Respiratory Effectiveness Group. / Use of electronic medical records and biomarkers to manage risk and resource efficiencies. In: European Clinical Respiratory Journal . 2017 ; Vol. 4, No. 1.
@article{fa84aa22a15a4d7899dcaf70e0b207a9,
title = "Use of electronic medical records and biomarkers to manage risk and resource efficiencies",
abstract = "The migration from paper to electronic medical records (EMRs) was motivated by the administrative need to record, retrieve and process increasing amounts of clinical data in the 1980s. In the intervening period, there has been growing recognition of the potential of such records for achieving care efficiencies, informing clinical decision making and real-life research. EMRs can be used to characterise patient groups, management approaches and differential outcomes. Characterisation can also help with identification of potential biomarkers for future risk determination and likely treatment response. The future heralds even greater opportunities through integration of clinical records and a range of technology-based solutions within a more complete electronic health record (EHR). Through application of algorithms based on identified risk predictors and disease determinants, clinical records could also be used to enable risk stratification of patients to optimise targeted interventions, conserving resources to achieve individual patient and system-wide benefit. In this review, we reflect on the evolution of the EMR and EHR and discuss current and emerging opportunities, particularly with respect to biomarkers and targeting of innovative biologic interventions. We also consider some of the critical issues associated with realising the potential of the EHR as a clinical aid and research tool in an age of emerging technologies.​​​​",
keywords = "electronic medical record (EMR), electronic health record (EHR), database, asthma, biomarker, primary care , CDSS, big data",
author = "Dermot Ryan and John Blakey and Alison Chisholm and David Price and Mike Thomas and Bj{\"o}rn St{\"a}llberg and Karin Lisspers and Kocks, {Janwillem W H} and {The Respiratory Effectiveness Group}",
year = "2017",
doi = "10.1080/20018525.2017.1293386",
language = "English",
volume = "4",
journal = "European Clinical Respiratory Journal",
issn = "2001-8525",
publisher = "Taylor & Francis",
number = "1",

}

TY - JOUR

T1 - Use of electronic medical records and biomarkers to manage risk and resource efficiencies

AU - Ryan, Dermot

AU - Blakey, John

AU - Chisholm, Alison

AU - Price, David

AU - Thomas, Mike

AU - Ställberg, Björn

AU - Lisspers, Karin

AU - Kocks, Janwillem W H

AU - The Respiratory Effectiveness Group

PY - 2017

Y1 - 2017

N2 - The migration from paper to electronic medical records (EMRs) was motivated by the administrative need to record, retrieve and process increasing amounts of clinical data in the 1980s. In the intervening period, there has been growing recognition of the potential of such records for achieving care efficiencies, informing clinical decision making and real-life research. EMRs can be used to characterise patient groups, management approaches and differential outcomes. Characterisation can also help with identification of potential biomarkers for future risk determination and likely treatment response. The future heralds even greater opportunities through integration of clinical records and a range of technology-based solutions within a more complete electronic health record (EHR). Through application of algorithms based on identified risk predictors and disease determinants, clinical records could also be used to enable risk stratification of patients to optimise targeted interventions, conserving resources to achieve individual patient and system-wide benefit. In this review, we reflect on the evolution of the EMR and EHR and discuss current and emerging opportunities, particularly with respect to biomarkers and targeting of innovative biologic interventions. We also consider some of the critical issues associated with realising the potential of the EHR as a clinical aid and research tool in an age of emerging technologies.​​​​

AB - The migration from paper to electronic medical records (EMRs) was motivated by the administrative need to record, retrieve and process increasing amounts of clinical data in the 1980s. In the intervening period, there has been growing recognition of the potential of such records for achieving care efficiencies, informing clinical decision making and real-life research. EMRs can be used to characterise patient groups, management approaches and differential outcomes. Characterisation can also help with identification of potential biomarkers for future risk determination and likely treatment response. The future heralds even greater opportunities through integration of clinical records and a range of technology-based solutions within a more complete electronic health record (EHR). Through application of algorithms based on identified risk predictors and disease determinants, clinical records could also be used to enable risk stratification of patients to optimise targeted interventions, conserving resources to achieve individual patient and system-wide benefit. In this review, we reflect on the evolution of the EMR and EHR and discuss current and emerging opportunities, particularly with respect to biomarkers and targeting of innovative biologic interventions. We also consider some of the critical issues associated with realising the potential of the EHR as a clinical aid and research tool in an age of emerging technologies.​​​​

KW - electronic medical record (EMR)

KW - electronic health record (EHR)

KW - database

KW - asthma

KW - biomarker

KW - primary care

KW - CDSS

KW - big data

U2 - 10.1080/20018525.2017.1293386

DO - 10.1080/20018525.2017.1293386

M3 - Article

VL - 4

JO - European Clinical Respiratory Journal

JF - European Clinical Respiratory Journal

SN - 2001-8525

IS - 1

M1 - 1293386

ER -